CMS Unveils Second Round of Negotiated Medicare Prices on 15 Drugs
- December 05, 2025
Medicare negotiated prices on the 15 high-spend drugs selected for the second round of the Inflation Reduction Act (IRA) program that are between 38% to 85% off the drugs’ list prices, the Centers for Medicare & Medicaid Services (CMS) announced November 25.
ARTICLE TAGS
You must be logged in to access this content.